PURE HA avec collagène
Natural health product licensed in Canada
- Other names
- PURE HA with collagen
- Licence holder
- Revelox Distribution
- NPN or DIN-HM
- 80078243
- Status
- Active licence
- Licence date
- 8 June 2017
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hydrolysat de kératine Source : Kératine hydrolysée | 125 milligramme | Not calculated |
| Collagène hydrolysé Source : Poissons - Os | 1,200 milligramme | Not calculated |
| Collagène hydrolysé Source : Poissons -Peau | 1,200 milligramme | Not calculated |
| Silicium Source : Dioxyde de silicium | 25 milligramme | Not calculated |
| Acide hyaluronique Source : Acide hyaluronique | 50 milligramme | Not calculated |
Non-medicinal ingredients
Glycérine, Eau purifiée, Benzoate de sodium, Sorbate de potassium, Malate d'éthyle, Gomme de xanthane, Extrait de tiges/feuilles de Stevia rebaudiana, Saveur de pomme verte
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 15 millilitre ; maximum: 15 millilitre | minimum: 1 day ; maximum: 1 day |
Uses authorised in Canada
Source de l'acide aminé essentiel lysine pour aider a la formation de collagène. Aide a maintenir la santé des cheveux, des ongles et de la peau. Aide au maintien d'articulations saines. Aide a réduire la douleur aux articulations associée a l'arthrose/l'ostéoarthrite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Certaines personnes pourraient expérimenter des dérangements gastro-intestinaux légers tels que de la diarhée, de la douleur abdominale, des brûlements, de la nausées ou des vomissements; si tel est le cas, cesser l'utilisation.
- Précautions et mises en garde
Si vous êtes enceinte ou si vous allaitez, consulter un praticien de soins de santé avant d'en faire l'usage. Si les symptômes s'aggravent, consulter un praticien de soins de santé.
Source
Official Health Canada record, licence 80078243
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.